Virtual CME Program
Brain Check: Promoting Brain Health and Detecting Cognitive Impairment
This session will equip primary care providers with essential strategies to promote brain health, delay or prevent mild cognitive impairment (MCI), and integrate cognitive screening into routine practice. Expert faculty will discuss risk factor modification and effective patient communication to support early detection and intervention for cognitive decline.
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 4/17/2025
Expiration Date: 4/17/2026
Learning Objectives
- Employ risk factor modification and other strategies to promote brain health and delay or prevent the onset of mild cognitive impairment (MCI)
- Discuss brain health and cognitive decline with patients as part of routine primary care practice
- Perform appropriate screening for cognitive impairment
Faculty
Amy Clouse, MD, FAAFP
Clinical Associate Professor of Family and Community Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania
Associate Director, Family Medicine Residency Program, Jefferson Health - Abington
Andrew E. Budson, MD
Chief of Cognitive Behavioral Neurology
Veterans Affairs Boston Healthcare System
Associate Director, Boston University Alzheimer’s Disease Research Center
Professor of Neurology, Boston University
Lecturer in Neurology, Harvard Medical School
Disclosures
The following relevant financial relationships have been disclosed by those in a position to influence the content of this activity. All have been mitigated by Pri-Med Institute:
Andrew Budson: Advisor for Eli Lilly and Abbvie, Contractor for Vox Neuro and Bristol Meyers Squibb
Amy Clouse: Stockholder in Eli Lilly and Novo Nordisk
All other individuals in control of content for this activity have disclosed no relevant financial relationships.
Supporters and Partners
Supported by
This activity is supported by an educational grant from Lilly
Education Partner
Pri-Med Institute
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions?
If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.